International Day of Older Persons: AOP Health Shines a Light on the Silent Burden of Venous Leg Ulcers
VIENNA–(BUSINESS WIRE)–#AOPHealth—On the United Nations’ International Day of Older Persons, AOP Health draws attention to the often-invisible... Read more.
Neural Concept Accelerates Integrated AI Adoption With 100% Enterprise Growth
The AI-first engineering platform reports a 100% surge in enterprise adoption, enabling OEMs to future-proof engineering with AI-driven, human-led workflows. Customers... Read more.
Visa Announces General Availability of VCS Hub; Ushers in a New Era of AI-Powered Commercial Payments Innovation
The future-ready platform is unlocking intelligent payments for issuers and fintechs SAN FRANCISCO–(BUSINESS WIRE)–Visa Inc. (NYSE: V), a global leader... Read more.
Exponents Ranked #1087 on the 2025 Inc. 5000
SAN DIEGO–(BUSINESS WIRE)–#BoothDesign–Inc., the only prominent brand focused solely on supporting owners and leaders of growing private businesses,... Read more.
ENHERTU® Demonstrated Highly Statistically Significant and Clinically Meaningful Improvement in Invasive Disease-Free Survival Versus T-DM1 in DESTINY-Breast05 Phase 3 Trial in Patients with High-Risk Early Breast Cancer Following Neoadjuvant Therapy
Second positive phase 3 trial of Daiichi Sankyo and AstraZeneca’s ENHERTU in HER2 positive early breast cancer reinforces its potential to become a foundational... Read more.
Corpay and Mastercard Move Extend Near Real-Time Payments to New Markets
Corpay’s business and financial institutional clients will benefit from near-real-time payouts to 22 new markets, leveraging Mastercard Move’s extensive network.... Read more.
Visa Growth Corporates Working Capital Index Reveals Rise of the Strategic Planner and Adaptable Accelerator Shaping the Future of Liquidity Management
Corporate CFOs and Treasurers harness AI, cards and digital tools to navigate growth and volatility SAN FRANCISCO–(BUSINESS WIRE)–Visa (NYSE:V), a global... Read more.
Infobric and Stirling Square Welcome KKR as New Investor
Investment supports the acceleration of Infobric’s growth in construction software solutions JÖNKÖPING, Sweden–(BUSINESS WIRE)–Stirling Square Capital... Read more.
PureTech Presents New Data from Phase 2b Open-Label Extension Study of Deupirfenidone (LYT-100), Further Supporting Strong and Durable Efficacy and Potential to Serve as New Standard of Care in IPF
Patients who switched from placebo or pirfenidone to deupirfenidone in the open-label extension study achieved stabilization of lung function with favorable tolerability... Read more.
Savara Presents New Data From the Phase 3 IMPALA-2 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the European Respiratory Society (ERS) Congress 2025
– The Beneficial Clinical Effects of Molgramostim Were Similar in Patients with aPAP Regardless of Disease Severity Defined by DLco% – – Changes in DLco%,... Read more.